Association of systemic corticosteroid use with prognosis of patients with acute exacerbations of chronic obstructive pulmonary disease in the intensive care unit: a propensity score-matched cohort study

Abstract Background Systemic corticosteroid has been recommended for the treatment of severe acute exacerbations of chronic obstructive pulmonary disease (AECOPD). Little is known about the use of systemic corticosteroid in patients admitted to intensive care units (ICU) since most of previous trial...

Full description

Saved in:
Bibliographic Details
Main Authors: Le Bai, Pengfei Zhu, Tingyu Pan, Yuanjie Liu, Yong Xu, Hailang He, Xianmei Zhou
Format: Article
Language:English
Published: BMC 2024-10-01
Series:BMC Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12916-024-03705-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850203637379235840
author Le Bai
Pengfei Zhu
Tingyu Pan
Yuanjie Liu
Yong Xu
Hailang He
Xianmei Zhou
author_facet Le Bai
Pengfei Zhu
Tingyu Pan
Yuanjie Liu
Yong Xu
Hailang He
Xianmei Zhou
author_sort Le Bai
collection DOAJ
description Abstract Background Systemic corticosteroid has been recommended for the treatment of severe acute exacerbations of chronic obstructive pulmonary disease (AECOPD). Little is known about the use of systemic corticosteroid in patients admitted to intensive care units (ICU) since most of previous trials excluded these critically ill patients. Methods We conducted a matched cohort study based on the Medical Information Mart in Intensive Care-IV database. Patients with AECOPD in ICUs were included. Patients in the exposure group should be intravenously administrated with methylprednisolone or treated with oral prednisone within 24 h after ICU admission. The propensity score matching and multivariable analyses were used to adjust for covariates. The primary outcome was 28-day mortality, and secondary outcomes included ICU mortality, in-hospital mortality, the duration of ICU stay, and mechanical ventilation. Subgroup analyses for the primary outcome were performed according to age, sex, type of corticosteroid, type of ICU admission, type of mechanical ventilation, and co-morbidities/complications. Results The entire cohort and the matched cohort included 763 and 412 patients, respectively. In the matched cohort, the use of systemic corticosteroid had no impact on 28-day mortality (OR: 1.00, 95% CI: 0.61–1.64, P = 1.000). The results kept consistent in all subgroups. Additionally, systemic corticosteroid showed no benefits on ICU mortality, in-hospital mortality, the length of ICU stay, and the duration of mechanical ventilation. Conclusions The results of this study do not support routine use of systemic corticosteroid in patients with AECOPD admitted to ICUs.
format Article
id doaj-art-97b6b9f7471e41e4817e3c4a07ac8b39
institution OA Journals
issn 1741-7015
language English
publishDate 2024-10-01
publisher BMC
record_format Article
series BMC Medicine
spelling doaj-art-97b6b9f7471e41e4817e3c4a07ac8b392025-08-20T02:11:26ZengBMCBMC Medicine1741-70152024-10-012211910.1186/s12916-024-03705-4Association of systemic corticosteroid use with prognosis of patients with acute exacerbations of chronic obstructive pulmonary disease in the intensive care unit: a propensity score-matched cohort studyLe Bai0Pengfei Zhu1Tingyu Pan2Yuanjie Liu3Yong Xu4Hailang He5Xianmei Zhou6Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese MedicineAffiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese MedicineAffiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese MedicineAffiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese MedicineSchool of Chinese Medicine, Nanjing University of Chinese MedicineAffiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese MedicineAffiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese MedicineAbstract Background Systemic corticosteroid has been recommended for the treatment of severe acute exacerbations of chronic obstructive pulmonary disease (AECOPD). Little is known about the use of systemic corticosteroid in patients admitted to intensive care units (ICU) since most of previous trials excluded these critically ill patients. Methods We conducted a matched cohort study based on the Medical Information Mart in Intensive Care-IV database. Patients with AECOPD in ICUs were included. Patients in the exposure group should be intravenously administrated with methylprednisolone or treated with oral prednisone within 24 h after ICU admission. The propensity score matching and multivariable analyses were used to adjust for covariates. The primary outcome was 28-day mortality, and secondary outcomes included ICU mortality, in-hospital mortality, the duration of ICU stay, and mechanical ventilation. Subgroup analyses for the primary outcome were performed according to age, sex, type of corticosteroid, type of ICU admission, type of mechanical ventilation, and co-morbidities/complications. Results The entire cohort and the matched cohort included 763 and 412 patients, respectively. In the matched cohort, the use of systemic corticosteroid had no impact on 28-day mortality (OR: 1.00, 95% CI: 0.61–1.64, P = 1.000). The results kept consistent in all subgroups. Additionally, systemic corticosteroid showed no benefits on ICU mortality, in-hospital mortality, the length of ICU stay, and the duration of mechanical ventilation. Conclusions The results of this study do not support routine use of systemic corticosteroid in patients with AECOPD admitted to ICUs.https://doi.org/10.1186/s12916-024-03705-4Chronic obstructive pulmonary diseaseIntensive care unitSystemic corticosteroidCohort study
spellingShingle Le Bai
Pengfei Zhu
Tingyu Pan
Yuanjie Liu
Yong Xu
Hailang He
Xianmei Zhou
Association of systemic corticosteroid use with prognosis of patients with acute exacerbations of chronic obstructive pulmonary disease in the intensive care unit: a propensity score-matched cohort study
BMC Medicine
Chronic obstructive pulmonary disease
Intensive care unit
Systemic corticosteroid
Cohort study
title Association of systemic corticosteroid use with prognosis of patients with acute exacerbations of chronic obstructive pulmonary disease in the intensive care unit: a propensity score-matched cohort study
title_full Association of systemic corticosteroid use with prognosis of patients with acute exacerbations of chronic obstructive pulmonary disease in the intensive care unit: a propensity score-matched cohort study
title_fullStr Association of systemic corticosteroid use with prognosis of patients with acute exacerbations of chronic obstructive pulmonary disease in the intensive care unit: a propensity score-matched cohort study
title_full_unstemmed Association of systemic corticosteroid use with prognosis of patients with acute exacerbations of chronic obstructive pulmonary disease in the intensive care unit: a propensity score-matched cohort study
title_short Association of systemic corticosteroid use with prognosis of patients with acute exacerbations of chronic obstructive pulmonary disease in the intensive care unit: a propensity score-matched cohort study
title_sort association of systemic corticosteroid use with prognosis of patients with acute exacerbations of chronic obstructive pulmonary disease in the intensive care unit a propensity score matched cohort study
topic Chronic obstructive pulmonary disease
Intensive care unit
Systemic corticosteroid
Cohort study
url https://doi.org/10.1186/s12916-024-03705-4
work_keys_str_mv AT lebai associationofsystemiccorticosteroidusewithprognosisofpatientswithacuteexacerbationsofchronicobstructivepulmonarydiseaseintheintensivecareunitapropensityscorematchedcohortstudy
AT pengfeizhu associationofsystemiccorticosteroidusewithprognosisofpatientswithacuteexacerbationsofchronicobstructivepulmonarydiseaseintheintensivecareunitapropensityscorematchedcohortstudy
AT tingyupan associationofsystemiccorticosteroidusewithprognosisofpatientswithacuteexacerbationsofchronicobstructivepulmonarydiseaseintheintensivecareunitapropensityscorematchedcohortstudy
AT yuanjieliu associationofsystemiccorticosteroidusewithprognosisofpatientswithacuteexacerbationsofchronicobstructivepulmonarydiseaseintheintensivecareunitapropensityscorematchedcohortstudy
AT yongxu associationofsystemiccorticosteroidusewithprognosisofpatientswithacuteexacerbationsofchronicobstructivepulmonarydiseaseintheintensivecareunitapropensityscorematchedcohortstudy
AT hailanghe associationofsystemiccorticosteroidusewithprognosisofpatientswithacuteexacerbationsofchronicobstructivepulmonarydiseaseintheintensivecareunitapropensityscorematchedcohortstudy
AT xianmeizhou associationofsystemiccorticosteroidusewithprognosisofpatientswithacuteexacerbationsofchronicobstructivepulmonarydiseaseintheintensivecareunitapropensityscorematchedcohortstudy